Metraipolis › archive › dc_debc2b68b51e

Effect of Nano-Gefitinib on Solid Ehrlich Carcinoma via Targeting EGFR, RIPK2 Pathways, and Macrophage Reprogramming — Europe PMC PMID:41304988

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41304988
DOI
10.3390/ph18111747
License (as archived)
solo-consultazione
Archived
2026-11-08T12:19:59.493Z
SHA-256 of the archived text
e77e756a342b3b47eaff766ab7f0f8a91c583230641deb5f7809480ac5d980e1
Stable URL of this page
https://metraipolis.com/documento/dc_debc2b68b51e

How to cite

Effect of Nano-Gefitinib on Solid Ehrlich Carcinoma via Targeting EGFR, RIPK2 Pathways, and Macrophage Reprogramming — Europe PMC PMID:41304988 — Europe PMC (en), https://europepmc.org/article/MED/41304988 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_debc2b68b51e (Metraipolis archive dc_debc2b68b51e, sha256 e77e756a342b3b47eaff766ab7f0f8a91c583230641deb5f7809480ac5d980e1)
BibTeX
@misc{dcdebc2b68b51e,
  title = {Effect of Nano-Gefitinib on Solid Ehrlich Carcinoma via Targeting EGFR, RIPK2 Pathways, and Macrophage Reprogramming — Europe PMC PMID:41304988},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41304988},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_debc2b68b51e; sha256 e77e756a342b3b47eaff766ab7f0f8a91c583230641deb5f7809480ac5d980e1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41304988. Agents can read the archived copy with the MCP tool read_document.